News tagged with tumor regression
RNA regulator of melanoma could be a new target for cancer therapy
Melanoma is the most deadly form of skin cancer, estimated by the National Cancer Institute to afflict more than 70,000 people in the United States annually and the incidence rate continues to rise. In a study published online ...
Cancer
May 10, 2012 |
5 / 5 (1) |
0
|
Researchers find potential solution to melanoma's resistance to vemurafenib
Researchers at Moffitt Cancer Center in Tampa, Fla., and colleagues in California have found that the XL888 inhibitor can prevent resistance to the chemotherapy drug vemurafenib, commonly used for treating patients with melanoma.
Cancer
Feb 28, 2012 |
not rated yet |
0
|
Novel drug combination offers therapeutic promise for hard-to-treat cancers
Researchers at Brigham and Women's Hospital (BWH) have identified a new combination of targeted therapies that, together, may treat two aggressive tumor types that until now have not had effective treatments. These findings ...
Cancer
Sep 12, 2011 |
5 / 5 (3) |
0
|
MRI predicts survival in locally advanced rectal cancer
A new study has shown that magnetic resonance imaging (MRI) used to evaluate responses to pre-surgery (neo-adjuvant) chemotherapy or radiation may predict survival among patients with advanced rectal cancer. The findings ...
Cancer
Aug 29, 2011 |
5 / 5 (1) |
0
|
Low T3 syndrome predicts unfavorable outcomes in surgical patients with brain tumor
In a study of 90 patients undergoing surgery for brain tumor, researchers in Lithuania (Lithuanian University of Health Sciences) and the United States (University of North Carolina at Chapel Hill and Brigham & Women's Hospital, ...
Neuroscience
Mar 12, 2013 |
not rated yet |
0
Hard-to-treat Myc-driven cancers may be susceptible to drug already used in clinic
Drugs that are used in the clinic to treat some forms of breast and kidney cancer and that work by inhibiting the signaling molecule mTORC1 might have utility in treating some of the more than 15 percent of human cancers ...
Cancer
Dec 14, 2012 |
not rated yet |
0
Stopping hormones might help breast cancer to regress
As soon as women quit hormone therapy, their rates of new breast cancer decline, supporting the hypothesis that stopping hormones can lead to tumor regression, according to a report e-published in Cancer Epidemiology, Bi ...
Cancer
Feb 28, 2012 |
not rated yet |
0
Preclinical study indicates potential for novel inhibitor to overcome drug resistance induced by RAF, MEK inhibitors
A new class of investigational medicines may help to treat patients with cancers driven by mutations in genes such as BRAF or KRAS/NRAS, including those patients who have become resistant to therapies that target BRAF directly, ...
Cancer
Apr 08, 2013 |
not rated yet |
0
Clinical trial targets advanced prostate cancer
Select patients with advanced prostate cancer may benefit from a Georgia Health Sciences University Cancer Center clinical trial that looks to improve survival rates of the FDA-approved prostate cancer drug Provenge.
Cancer
Dec 03, 2012 |
5 / 5 (1) |
0
Study shows bone fluoride levels not associated with osteosarcoma
The International and American Associations for Dental Research have released in its Journal of Dental Research a study that investigated bone fluoride levels in individuals with osteosarcoma, which is a rare, primary malign ...
Cancer
Jul 28, 2011 |
not rated yet |
0
